During 14-17/09/2023, at Grecotel Filoxenia/KALAMATA, the Society for the Study of Dermatovenereologic and Allergic Diseases (S.S.D.A.D.) organized the 6th Panhellenic Conference “Dermatological diseases: Past, present and future”.
Dermatologists from all over Greece who attended the Conference had the chance to visit IASIS PHARMA exhibition stand and received information about IASIS major Dermatological products:
- Isotroin®/Isotretinoin (in the new & unique 30mg dosage) indicated for severe forms of acne that are resistant to treatment with systemically administered antibiotics and topical therapy,
- Combi®, a combination of fluprednidene+miconazole cream for the treatment of Inflammatory Dermatomycoses
- Modiwart®/Ιmiquimod, an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic keratoses.